CJASN Editorial Team Disclosures 2018

Size: px
Start display at page:

Download "CJASN Editorial Team Disclosures 2018"

Transcription

1 CJASN Editorial Team Disclosures 2018 Editor in Chief Rajnish Mehrotra, MD, MBBS, FASN Organization Name: University of Washington Current Employer: University of Washington, Seattle, WA Scientific Advisor/Membership: Editor-in-Chief, Clinical Journal of the American Society of Nephrology; Member, Exam Committee of the American Board of Internal Medicine; Editorial Board for Journal of Renal Nutrition, Peritoneal Dialysis International; Other Interests/Relationships: Member, Board of Trustees, Northwest Kidney Centers Disclosure Expiration Date: 3/23/2019 PAGE 1 UPDATED 4/24/2018

2 Deputy Editors Michel Chonchol, MD, FASN Organization Name: University of Colorado Current Employer: University of Colorado Denver Research Funding: OTSUKA, Corvidia. Scientific Advisor/Membership: n/a Disclosure Expiration Date: 3/28/2019 PAGE 2 UPDATED 4/24/2018

3 Ian H. de Boer, MD, MS Organization Name: Division of Nephrology and Kidney Research Institute, University of Washington Current Employer: University of Washington Consultancy Agreements: Boehringer-Ingelheim, Ironwood Pharmaceuticals Research Funding: MedTronic (research equipment and supplies), Abbott (research supplies) Scientific Advisor/Membership: Deputy Editor: Clinical Journal of the American Society of Nephrology Editorial Board: Kidney International Editorial Advisory Board: American Family Physician Professional Practice Committee, American Diabetes Association Other Interests/Relationships: Research funding from the American Diabetes Association Disclosure Expiration Date: 1/10/2019 PAGE 3 UPDATED 4/24/2018

4 Editor at Large, Clinical Practice Mitchell H. Rosner, MD, FASN Organization Name: University of Virginia School of Medicine Current Employer: University of Virginia Consultancy Agreements: Baxter Research Funding: Kadmon and National Institutes of Health Honoraria: American Society of Nephrology and Baxter Scientific Advisor/Membership: American Society of Nephrology Disclosure Expiration Date: 4/19/2019 PAGE 4 UPDATED 4/24/2018

5 Associate Editors Christopher T. Chan, MD Organization Name: Toronto General Hospital Current Employer: Toronto General Hospital, University Health Network Consultancy Agreements: Baxter, NxStage, Medtronic Scientific Advisor/Membership: Baxter, NxStage, Medtronic Disclosure Expiration Date: 4/18/2019 PAGE 5 UPDATED 4/24/2018

6 David M. Charytan, MD Organization Name: Brigham and Women's Hospital/Harvard Medical School Current Employer: Brigham & Women's Hospital/Harvard Medical School Consultancy Agreements: Medtronic, Boehringer Ingelheim, Janssen (steering committee), PLC medical (clinical events committee), Astra Zenneca (DSMB) Allena Pharmaceuticals (DSMB) Research Funding: Medtronic-clinical trial support Bioporto-clinical trial support Scientific Advisor/Membership: CJASN, Medtronic, Boehringer Ingelheim Other Interests/Relationships: Expert Witness Fees Related to Proton Pump Inhibitors Disclosure Expiration Date: 4/10/2019 PAGE 6 UPDATED 4/24/2018

7 Richard Nicholas Formica, Jr., MD Organization Name: Yale School of Medicine Current Employer: Yale School of Medicine Consultancy Agreements: Alexion Research Funding: Bristol Myers PI for trial, no salary support. Scientific Advisor/Membership: Veloxis Pharmaceuticals Other Interests/Relationships: 1. Secretary, American Society of Transplantation. 2. January 1, 2018 Scientific Registry of Transplant Recipients Visiting Committee Disclosure Expiration Date: 3/28/2019 PAGE 7 UPDATED 4/24/2018

8 Orlando M. Gutierrez, MD Organization Name: UAB School of Medicine Current Employer: UAB School of Medicine Consultancy Agreements: Keryx PharmaceuticalsAmgenHope Pharmaceuticals Research Funding: GlaxoSmithKline and Keryx Honoraria: AmgenKeryx Scientific Advisor/Membership: n/a Disclosure Expiration Date: 3/23/2019 PAGE 8 UPDATED 4/24/2018

9 Manjula Kurella Tamura, MD, MPH Organization Name: Stanford University Current Employer: VA Palo Alto Health Care System & Stanford University Scientific Advisor/Membership: CJASN Editorial Board Disclosure Expiration Date: 4/9/2019 PAGE 9 UPDATED 4/24/2018

10 Rulan S. Parekh, MD, MS, FASN Organization Name: The Hospital For Sick Children Current Employer: The Hospital For Sick Children and University Health Network Ownership Interests: Synaptive- Stock Research Funding: NIH, Canadian Institute of Health Research (CIHR), Astellas Scientific Advisor/Membership: CJASN, BMC Nephrology Disclosure Expiration Date: 4/4/2019 PAGE 10 UPDATED 4/24/2018

11 Charles D. Pusey, FASN Organization Name: Imperial College London Current Employer: Imperial College London Research Funding: GlaxoSmithKline Honoraria: Med Update Europe Scientific Advisor/Membership: Cell Medica Scientific Advisory Board; Editorial boards - Journal of the American Society for Nephrology, Nephrology Dialysis Transplantation, Clinical Journal of the American Society of Nephrology Disclosure Expiration Date: 4/5/2019 PAGE 11 UPDATED 4/24/2018

12 Mahboob Rahman, MD Organization Name: Case Western Reserve University Current Employer: Case Western Reserve University Research Funding: Bayer pharmaceuticals Scientific Advisor/Membership: Associate Editor, CJASN, Editorial Board member, American Journal of Nephrology Other Interests/Relationships: Medical Advisory Board, Kidney Foundation of Ohio Disclosure Expiration Date: 4/18/2019 PAGE 12 UPDATED 4/24/2018

13 Stephen L. Seliger, MD, MS Organization Name: University of Maryland School of Medicine Current Employer: University of Maryland School of Medicine, Baltimore VA Medical Center Consultancy Agreements: Abbvie Inc (Endpoint Adjudication Committee, SONAR trial) Research Funding: Roche Diagnostics, Inc., Otsuka American Pharmaceutical, Inc., Abbott Diagnostics, and Kadmon Pharmaceuticals Scientific Advisor/Membership: Associate Editor - Clinical Journal of the American Society of Nephrology; Member, Medical Review Board, ESRD Network 5.Member Endpoint Adjudication Committee, SONAR clinical trial (Abbvie, Inc). Member, Editorial Board - Circulation Disclosure Expiration Date: 3/28/2019 PAGE 13 UPDATED 4/24/2018

14 Edward D. Siew, MD, MS Organization Name: Vanderbilt University School of Medicine Current Employer: Vanderbilt University School of Medicine, Nashville Veterans Affairs Scientific Advisor/Membership: Editorial board of CJASN Disclosure Expiration Date: 4/5/2019 PAGE 14 UPDATED 4/24/2018

15 Christoph Wanner, MD Organization Name: University Hospital Current Employer: University Hospital Consultancy Agreements: Sanofi-Genzyme, Boehringer-Ingelheim, Bayer, Actelion, Abbvie Research Funding: Genyzme grant to institution. Actelion grant to institution Honoraria: Sanofi-Genzyme, Boehringer-Ingelheim, Abbvie, Bayer, Shire Scientific Advisor/Membership: n/a Disclosure Expiration Date: 3/28/2019 PAGE 15 UPDATED 4/24/2018

16 Statistical Editors Ronit Katz, PhD Organization Name: University of Washington Current Employer: University of Washington Consultancy Agreements: TAI Diagnostics, UCSF, UCSD Scientific Advisor/Membership: CJASN Editorial Board Disclosure Expiration Date: 4/16/2019 PAGE 16 UPDATED 4/24/2018

17 Leila R. Zelnick, PhD Organization Name: Kidney Research Institute Current Employer: University of Washington Consultancy Agreements: Microsoft Research Scientific Advisor/Membership: n/a Disclosure Expiration Date: 4/10/2019 PAGE 17 UPDATED 4/24/2018

18 Visual Abstract Editors Beatrice P. Concepcion, MD, FASN Organization Name: Vanderbilt University Medical Center Current Employer: Vanderbilt University Scientific Advisor/Membership: n/a Disclosure Expiration Date: 3/29/2019 PAGE 18 UPDATED 4/24/2018

19 Pablo Garcia, MD Organization Name: Saint Peter's University Hospital Current Employer: Saint Peter's University Hospital Scientific Advisor/Membership: n/a Disclosure Expiration Date: 4/4/2019 PAGE 19 UPDATED 4/24/2018

20 Kartik Kalra, MD Organization Name: Saint Peters University Hospital Current Employer: Saint Peter's University Hospital Scientific Advisor/Membership: CJASN visual abstract editor Disclosure Expiration Date: 4/17/2019 PAGE 20 UPDATED 4/24/2018

21 Edgar V. Lerma, MD, FASN Organization Name: Associates in Nephrology Current Employer: Associates in Nephrology Ownership Interests: Fresenius Joint Venture Honoraria: UpToDate, McGraw-Hill Publishing, Elsevier Publishing, Wolters Kluwer Publishing, Emedicine, National Kidney Foundation Scientific Advisor/Membership: Journal of Clinical Liipidology, International Urology and Nephrology Journal, Journal of Vascular Access, Prescribers Letter, Renal and Urology News, ASN Kidney News, Reviews in Endocrinology and Metabolic Disorders, American Journal of Kidney Diseases B Disclosure Expiration Date: 4/17/2019 PAGE 21 UPDATED 4/24/2018

22 Michelle Lim, MBChB Organization Name: NHS Tayside Current Employer: NHS Tayside Scientific Advisor/Membership: n/a Disclosure Expiration Date: 4/24/2019 PAGE 22 UPDATED 4/24/2018

23 Michelle N. Rheault, MD Organization Name: University of Minnesota Current Employer: University of Minnesota Research Funding: Amgen, Regulus Therapeutics, Retrophin, Reata, Novartis Scientific Advisor/Membership: CJASN Visual Abstract editor, Alport Syndrome Foundation Medical Advisory Board Other Interests/Relationships: Steering Committee: Midwest Pediatric Nephrology Consortium; Member: American Board of Pediatrics, Pediatric Nephrology SubBoard Disclosure Expiration Date: 4/17/2019 PAGE 23 UPDATED 4/24/2018

24 Joel M. Topf, MD Organization Name: Current Employer: Saint Clair Special Physicians Ownership Interests: Davita Scientific Advisor/Membership: American Journal of Kidney Disease, ASN, CJASN Other Interests/Relationships: author of Precious Bodily Fluids blog, editor of NephMadness, co-creator of NephJC, Author of Nephrology Secrets Disclosure Expiration Date: 4/17/2019 PAGE 24 UPDATED 4/24/2018

25 Editors-in-Chief, Emeritus William M. Bennett, MD, FASN Organization Name: Legacy Good Samaritan Medical Center Current Employer: Legacy Good Samaritan Medical Center Honoraria: ASN Scientific Advisor/Membership: n/a Disclosure Expiration Date: 1/22/2019 PAGE 25 UPDATED 4/24/2018

26 Gary C. Curhan, MD, FASN Organization Name: Channing Division of Network Medicine, Brigham and Women's Hospital Current Employer: Channing Division of Network Medicine, Brigham and Women's Hospital Consultancy Agreements: Allena Pharmaceuticals, Shire, RenalGuard Ownership Interests: Allena Pharmaceuticals Research Funding: Allena Pharmaceuticals Scientific Advisor/Membership: n/a Other Interests/Relationships: Section Editor, UpToDate Disclosure Expiration Date: 4/12/2019 PAGE 26 UPDATED 4/24/2018

27 Managing Editor Shari Leventhal Organization Name: American Society of Nephrology Current Employer: American Society of Nephrology Scientific Advisor/Membership: n/a Other Interests/Relationships: Council of Science Editors - Program Committee Member, voluntary; ISMTE- Poster Committee Chair, voluntary Disclosure Expiration Date: 4/4/2019 PAGE 27 UPDATED 4/24/2018

CLINICAL GUIDELINES COMMITTEE September 9-10, 2014 DISCLOSURE OF INTERESTS

CLINICAL GUIDELINES COMMITTEE September 9-10, 2014 DISCLOSURE OF INTERESTS CLINICAL GUIDELINES COMMITTEE September 9-10, 2014 DISCLOSURE OF INTERESTS NAME Financial INTERESTS Non-Financial Thomas Denberg, MD, PhD, FACP, Chair Michael J. Barry, MD, MACP Indicate Employment: Carilion

More information

Organizational, or Other Financial Benefit None None None None None None. None None None None None None

Organizational, or Other Financial Benefit None None None None None None. None None None None None None Comprehensive Relationships With Industry and Other Entities AHA/ACC 2017 Update of ST-Elevation Myocardial Infarction and Non ST-Elevation Myocardial Infarction Measures Committee Jneid Hani, Chair Baylor

More information

AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH INDUSTRY AND OTHERS

AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH INDUSTRY AND OTHERS 2013 ACCF/AHA Guideline for the Management of Heart Failure ONLINE AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH INDUSTRY AND OTHERS (May 2013) Member Employment Consultant Speaker s Bureau Personal

More information

HOME DIALYSIS THERAPIES

HOME DIALYSIS THERAPIES Conference on HOME DIALYSIS Goldwurm Auditorium 1425 Madison Avenue Course Directors John C. He, MD, PhD Peter Kotanko, MD, FASN Jaime Uribarri, MD Jointly Provided by: Department of Medicine, Division

More information

in patients with diabetes, nephropathy and/or chronic kidney disease Summary of recommendations July 2017

in patients with diabetes, nephropathy and/or chronic kidney disease Summary of recommendations July 2017 Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and reninangiotensin-aldosterone system blockade in patients with diabetes, nephropathy

More information

The vexing problem of suboptimal initiation of dialysis: Can we do better?

The vexing problem of suboptimal initiation of dialysis: Can we do better? Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,

More information

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University

More information

George A. Gregory, M.D. Dean B. Andropoulos, M.D.

George A. Gregory, M.D. Dean B. Andropoulos, M.D. George A. Gregory, M.D. Dean B. Andropoulos, M.D. ANESTHESIA CARE OF PEDIATRIC PATIENTS IN DEVELOPING COUNTRIES Edited by: George A. Gregory Professor Emeritus Departments of Anesthesia and Pediatrics

More information

REGISTER OF INTERESTS SIGN guideline 154: Pharmacological management of glycaemic control in people with type 2 diabetes Published: 29 November 2017

REGISTER OF INTERESTS SIGN guideline 154: Pharmacological management of glycaemic control in people with type 2 diabetes Published: 29 November 2017 CHAIR John Petrie, Professor of Diabetic Medicine Financial Non-financial Non-personal Last updated Specific Non-Specific Specific Non- Specific Professor of Diabetic Medicine, University of Glasgow Academic.

More information

nephropathy and/or chronic kidney disease Summary of recommendations

nephropathy and/or chronic kidney disease Summary of recommendations July 2017 Guidelines: Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and reninangiotensin-aldosterone system blockade in patients

More information

Key ASCO Presentations Issue 4, Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM)

Key ASCO Presentations Issue 4, Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM) Key ASCO Presentations Issue 4, 2010 Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM) For more visit ResearchToPractice.com/5MJCMT2010 CME INFORMATION OVERVIEW OF

More information

WORK GROUP BIOGRAPHIES

WORK GROUP BIOGRAPHIES John W. Adamson, MD, has served as Executive Vice President for Research and Director of the Blood Research Institute of the Blood Center of Southeastern Wisconsin in Milwaukee since 1998. He holds the

More information

NAME CTS AFFILIATION DISCLOSURE UPDATED

NAME CTS AFFILIATION DISCLOSURE UPDATED NAME CTS AFFILIATION DISCLOSURE UPDATED Darcy Marciniuk (Chair) and Canadian and Canadian COPD Alliance Consultant Fee, Speaker s Bureau, Advisory Committee: AstraZeneca, Boehringer-Ingelheim, Canadian

More information

Clinical Guidelines Committee (CGC) February 25-26, 2014 DISCLOSURE OF INTERESTS

Clinical Guidelines Committee (CGC) February 25-26, 2014 DISCLOSURE OF INTERESTS Clinical Guidelines Committee (CGC) February 25-26, 2014 DISCLOSURE OF INTERESTS NAME Financial INTERESTS Non-Financial Thomas D. Denberg, MD, PhD, FACP, Chair Michael J. Barry, MD, MACP Employment: Carilion

More information

NEWS BRIEFING Adjunctive Therapies in Type 1 and Type 2 Diabetes

NEWS BRIEFING Adjunctive Therapies in Type 1 and Type 2 Diabetes NEWS BRIEFING Adjunctive Therapies in Type 1 and Type 2 Diabetes Moderated by: Bernard Zinman, MD, CM, FRCPC, FACP Lunenfeld-Tanenbaum Research Institute and University of Toronto Mount Sinai Hospital

More information

University of California, Los Angeles, Los Angeles, CA, 2 FROS Radiation Oncology and CyberKnife Center, Flushing, NY, 3

University of California, Los Angeles, Los Angeles, CA, 2 FROS Radiation Oncology and CyberKnife Center, Flushing, NY, 3 Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study A. U. Kishan 1, A. Katz 2, C. A. Mantz 3, F. I.

More information

Dialysis outcomes: can we do better?

Dialysis outcomes: can we do better? Dialysis outcomes: can we do better? Allan J. Collins, MD, FACP Professor of Medicine University of Minnesota Director, Chronic Disease Research Group Minneapolis Medical Research Foundation Director,

More information

Evidence grades for the recommendations

Evidence grades for the recommendations Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy

More information

ESC Heart & Brain Workshop

ESC Heart & Brain Workshop Supported by Bayer, Bristol-Myers Squibb and Pfizer Alliance, Boehringer Ingelheim, Daiichi Sankyo Europe GmbH and Medtronic in the form of educational grants. The scientific programme has not been influenced

More information

Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES

Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES All individuals able to influence or control content of any CME certified activity that will be presented were required to complete

More information

Intensive Board Review Course. Faculty. August 9-11, 2018 Hyatt Regency Minneapolis Minneapolis, MN

Intensive Board Review Course. Faculty. August 9-11, 2018 Hyatt Regency Minneapolis Minneapolis, MN Intensive Board Review Course Faculty August 9-11, 2018 Hyatt Regency Minneapolis Minneapolis, MN Janet Bull, MD MBA FAAHPM Dr. Bull is the Chief Medical Officer at Four Seasons Compassion and holds a

More information

Renal Endorsement Maintenance Steering Committee Member Roster

Renal Endorsement Maintenance Steering Committee Member Roster Renal Endorsement Maintenance Steering Committee Member Roster Peter Crooks, MD (Co-Chair) Associate Medical Director for Operations Southern California Permanente Medical Group Peter Crooks, MD, is associate

More information

Membership of cirrhosis guideline Committee

Membership of cirrhosis guideline Committee Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the

More information

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016 RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney

More information

Core Concepts in Hypertension in Kidney Disease

Core Concepts in Hypertension in Kidney Disease Core Concepts in Hypertension in Kidney Disease Ajay K. Singh Rajiv Agarwal Editors Core Concepts in Hypertension in Kidney Disease Editors Ajay K. Singh Global and Continuing Education Harvard Medical

More information

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn Letter Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, openlabel study J. Rosenstock 1,2,

More information

t 11,028 FOLLOWERS f 19,240 FANS l 2,517 FOLLOWERS

t 11,028 FOLLOWERS f 19,240 FANS l 2,517 FOLLOWERS 216 OVERVIEW 16,824 MEMBERS REPRESENTING 124 COUNTRIES 4,594,81 UNIQUE VISITS TO ASN WEBSITE 13,351 KIDNEY WEEK PARTICIPANTS IMPACT FACTORS 8.49 JASN 19,337 KIDNEY NEWS CIRCULATION 4.7 CJASN Latest available

More information

NATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT)

NATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT) Strategy for Patient-Oriented Research Putting Patients First VISION Can-SOLVE CKD Network Vision: By 2020, every Canadian with, or at high risk for, chronic kidney (CKD) will receive the best recommended

More information

JEADV SHORT REPORT. Abstract

JEADV SHORT REPORT. Abstract DOI: 1.1111/jdv.14738 JEADV SHORT REPORT Safety and efficacy of through 14 weeks in patients with moderate to severe psoriasis who continued on or switched from etanercept treatment: findings from the

More information

Nitin S. Damle, Disclosure of Interests American College of Physicians

Nitin S. Damle, Disclosure of Interests American College of Physicians Nitin S. Damle, Dr. Damle discloses the following interests: South County Internal Medicine Inc (null) Employment: Grants/Contracts: null (null) Speaker's Bureaus: Executive Boards: Consulting/Honoraria:

More information

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016 RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney

More information

Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML

Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML CME INFORMATION OVERVIEW OF ACTIVITY Acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) account for approximately

More information

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis (UNVEIL Phase IV Study)

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis (UNVEIL Phase IV Study) 4892 Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis ( Phase IV Study) Bruce Strober, MD 1 ; Jerry Bagel, MD 2 ; Mark Lebwohl, MD 3 ; Linda Stein Gold, MD 4 ; J. Mark Jackson,

More information

This article is a CME/CE certified activity. To earn credit for this activity visit:

This article is a CME/CE certified activity. To earn credit for this activity visit: Novel Perspectives on Type 2 Diabetes: Traditional and Emerging Therapies and the Potential Role of the Kidneys This article is a CME/CE certified activity. To earn credit for this activity visit: www.medscape.org/lecture/t2dm-therapies

More information

Miklos Z. Molnar, MD, PhD, FASN - Curriculum Vitae. Personal Statistics: Born: February 17th, 1977 Place of Birth: Budapest, Hungary.

Miklos Z. Molnar, MD, PhD, FASN - Curriculum Vitae. Personal Statistics: Born: February 17th, 1977 Place of Birth: Budapest, Hungary. Miklos Z. Molnar, MD, PhD, FASN - Curriculum Vitae Personal Statistics: Born: February 17th, 1977 Place of Birth: E-mail: mzmolnar@uthsc.edu Education: 1991-1995 High School, Budapest June 7, 1995 09/1995-08/2001

More information

Immunology and Immunotherapy 101 for the non-immunologist

Immunology and Immunotherapy 101 for the non-immunologist Immunology and Immunotherapy 101 for the non-immunologist SITC Advances in Immunotherapy Seattle, WA 2016 Laura QM Chow Associate Professor University of Washington Associate Professor, Fred Hutchison

More information

ENDOCRINOLOGY FOR PRIMARY CARE

ENDOCRINOLOGY FOR PRIMARY CARE ENDOCRINOLOGY FOR PRIMARY CARE Las Vegas, Nevada The Cosmopolitan February 27 March 1, 2015 Participating Faculty Gregory A. Brent, MD Professor, Departments of Medicine and Physiology David Geffen School

More information

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 13, 2017 Disclosures statement: Consultant: Allena, Becker

More information

Promius Pharma, a subsidiary of Dr. Reddy s Laboratories, Princeton, NJ; 2 Vedanta Research, Chapel Hill, NC; 3

Promius Pharma, a subsidiary of Dr. Reddy s Laboratories, Princeton, NJ; 2 Vedanta Research, Chapel Hill, NC; 3 Triptan Use and Discontinuation Among a Population Sample of Persons with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study Aftab Alam, MBBS, MS, MBA 1 ; Sagar Munjal, MD 1

More information

NCDR.17 Poster Abstract Reviewers

NCDR.17 Poster Abstract Reviewers NCDR.17 Poster Abstract Reviewers Name Anderson, Cornelia Armstrong, Ehrin J., MD Attaran, Robert, MD Beatty, Alexis Blankenship, James, MD Bonner, David Bradley, Steve Casey, Patricia Cha, Yong-Mei, MD

More information

Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES

Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES All individuals able to influence or control content of any CME certified activity that will be presented were required to complete

More information

Key ASH Presentations Issue 2, Lenalidomide in the Management of Chronic Lymphocytic Leukemia (CLL)

Key ASH Presentations Issue 2, Lenalidomide in the Management of Chronic Lymphocytic Leukemia (CLL) Key ASH Presentations Issue 2, 2011 Lenalidomide in the Management of Chronic Lymphocytic Leukemia (CLL) For more visit ResearchToPractice.com/5MJCASH2011 CME INFORMATION OVERVIEW OF ACTIVITY The annual

More information

HEATHER S. HOWARD, PHD, MPH

HEATHER S. HOWARD, PHD, MPH HEATHER S. HOWARD, PHD, MPH The Center for Sexual Health and Rehabilitation 1420 Jones Street, Suite 7, California 94109 415.683.3231 www.sexualrehab.com MISSION My mission as a sexologist and mind-body

More information

Journal of the American College of Cardiology

Journal of the American College of Cardiology Advertisement Journal of the American College of Cardiology Volume 72, Issue 3, July 2018 DOI: 10.1016/j.jacc.2018.04.063 PDF Article Download Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory

More information

APD and its new frontier. Roberto Pecoits-Filho, MD, PhD, FACP, FASN

APD and its new frontier. Roberto Pecoits-Filho, MD, PhD, FACP, FASN APD and its new frontier Roberto Pecoits-Filho, MD, PhD, FACP, FASN STARCH Study Phase IV Randomised (1:1) Parallel groups Multi-centre Nephrol Dial Transpl 2015 Nov;30(11):1905-11. Non-diabetic APD

More information

Applicability and Cost Implications for PCKS9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights from the Department of Veterans Affairs

Applicability and Cost Implications for PCKS9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights from the Department of Veterans Affairs Applicability and Cost Implications for PCKS9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights from the Department of Veterans Affairs Running Title: Virani et al.; Applicability and Cost Implications

More information

KDIGO CAN WE PREVENT SUDDEN DEATH IN DIALYSIS PATIENTS? Charles A. Herzog, M.D., FACC, FAHA

KDIGO CAN WE PREVENT SUDDEN DEATH IN DIALYSIS PATIENTS? Charles A. Herzog, M.D., FACC, FAHA CAN WE PREVENT SUDDEN DEATH IN DIALYSIS PATIENTS? Charles A. Herzog, M.D., FACC, FAHA Professor of Medicine, Hennepin County Medical Center/University of Minnesota Minneapolis, Minnesota USA Charles A.

More information

ESMO Symposium on Immuno-Oncology Programme book

ESMO Symposium on Immuno-Oncology Programme book IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org

More information

Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative

Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative Gregg C. Fonarow MD, Xin Zhao MS, Eric E. Smith MD, MPH, Jeffrey L. Saver MD, Mathew J. Reeves

More information

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well mthree TrEATMENT MODALITIES 7 ž 21 ATLAS OF ESRD IN THE

More information

Disclosures. Dr. Scirica has also served as a consultant for Lexicon, Arena, Gilead, and Eisai.

Disclosures. Dr. Scirica has also served as a consultant for Lexicon, Arena, Gilead, and Eisai. Disclosures Benjamin M. Scirica, MD, MPH, is employed by the TIMI Study Group, which has received research grants from Abbott, AstraZeneca, Amgen, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb,

More information

Pediatric Kidney Transplantation

Pediatric Kidney Transplantation Pediatric Kidney Transplantation Vikas Dharnidharka, MD, MPH Associate Professor Division of Pediatric Nephrology Conflict of Interest Disclosure Vikas Dharnidharka, MD, MPH Employer: University of Florida

More information

Apixaban versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with Atrial Fibrillation Scheduled for Cardioversion: The EMANATE Trial

Apixaban versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with Atrial Fibrillation Scheduled for Cardioversion: The EMANATE Trial Apixaban versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with Atrial Fibrillation Scheduled for Cardioversion: The EMANATE Trial Michael D. Ezekowitz, Professor, Sidney Kimmel Medical

More information

Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative

Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative Gregg C. Fonarow MD, Xin Zhao MS, Eric E. Smith MD, MPH, Jeffrey L. Saver MD, Mathew J. Reeves

More information

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN

What Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN Changing Lives and Making a Difference: Home Hemodialysis Stories Brigitte Schiller, MD, FACP, FASN Chief Medical Officer Satellite Healthcare What Happened? We started building centers We started peritoneal

More information

Summer 2013 Research Opportunity

Summer 2013 Research Opportunity Summer 2013 Research Opportunity Conduct research during summer of 2013 (June 1-August 1) under direction of a Vanderbilt scientist (stipend provided) Laboratory-based, clinical or translational research

More information

(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)

(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA) Secukinumab in Psoriasis Patients with Concurrent Psoriatic Arthritis: Patient-Reported Outcomes in the Corrona Psoriasis Registry AB Gottlieb, B Strober, 2 AW Armstrong, 3 JD Greenberg, 4,5 C Karki, 4

More information

Welcome and PRO Consortium Update

Welcome and PRO Consortium Update Welcome and PRO Consortium Update Stephen Joel Coons, PhD Executive Director, PRO Consortium FIFTH ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP April 29-30, 2014 Silver Spring, MD Co-sponsored

More information

New Horizons The Future of IPF and ILD

New Horizons The Future of IPF and ILD New Horizons The Future of IPF and ILD Talmadge E. King, Jr., M.D. Julius R. Krevans Distinguished Professorship in Internal Medicine Chair, Department of Medicine University of California San Francisco

More information

John Ansell President, John Ansell Consultancy Thame, UK

John Ansell President, John Ansell Consultancy Thame, UK Rutgers University Monday 29 September 2014 Co Eli Lilly Bristol-Myers Squibb Novo Nordisk Pfizer GlaxoSmithKline Takeda Sanofi Novartis AstraZeneca Roche Otsuka Johnson & Johnson Otsuka Abbott Teva 1

More information

The Effects of Daclizumab High Yield Process (DAC HYP) on Patient Centered Functional Outcomes: Results From the DECIDE Study

The Effects of Daclizumab High Yield Process (DAC HYP) on Patient Centered Functional Outcomes: Results From the DECIDE Study 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers May 27 30, 2015 Indianapolis, IN The Effects of Daclizumab High Yield Process () on Patient Centered Functional Outcomes: Results From

More information

FACULTY. James Daubert, MD, FACC Chief, Cardiac Electrophysiology Professor of Medicine Duke University

FACULTY. James Daubert, MD, FACC Chief, Cardiac Electrophysiology Professor of Medicine Duke University FACULTY William Abraham, MD, FACC, FHFSA, Physiology, and Cell Biology Director and Chair, Division of Cardiovascular Medicine Associate Dean for Clinical Research Director, Clinical Trials Management

More information

STEMI Care 2014 at the Crossroads: Taking the right road

STEMI Care 2014 at the Crossroads: Taking the right road STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,

More information

Targeted Agent and Profiling Utilization Registry

Targeted Agent and Profiling Utilization Registry Targeted Agent and Profiling Utilization Registry Richard L. Schilsky, MD, FACP, FASCO Senior Vice President and Chief Medical Officer American Society of Clinical Oncology Disclosure Information Richard

More information

New Prognostic Markers in Acute Myeloid Leukemia (AML)

New Prognostic Markers in Acute Myeloid Leukemia (AML) New Prognostic Markers in Acute Myeloid Leukemia (AML) For more visit ResearchToPractice.com/5MJCMDSAML CME INFORMATION OVERVIEW OF ACTIVITY Acute myeloid leukemia (AML) and the myelodysplastic syndromes

More information

Industry Relationships and Institutional Affiliations

Industry Relationships and Institutional Affiliations Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated daily statin: results from the ODYSSEY COMBO II study Christopher

More information

Summer 2015 Research Opportunity

Summer 2015 Research Opportunity Summer 2015 Research Opportunity Conduct research during the summer of 2015 (June 1-August 6) under the direction of a Vanderbilt scientist (stipend provided, approximately $1,800/month) Laboratory-based,

More information

t 14,081 FOLLOWERS f 28,855 FANS l 2,879 FOLLOWERS

t 14,081 FOLLOWERS f 28,855 FANS l 2,879 FOLLOWERS 7 OVERVIEW 8,8 MEMBERS REPRESENTING 4 COUNTRIES,68,7 UNIQUE VISITS TO ASN WEBSITE,96 KIDNEY WEEK PARTICIPANTS IMPACT FACTORS 8.97 JASN 9,78 KIDNEY NEWS CIRCULATION NONMEMBER - 9,8 4.78 CJASN Latest available

More information

Patient 1: 31-Year-Old Female. Fingolimod treatment

Patient 1: 31-Year-Old Female. Fingolimod treatment Cell Counts (10 9 /L) Cell Count ( 10 9 /L) Cell Count ( 10 9 /L) Cell Count ( 10 9 /L) Cell Count ( 10 9 /L) Cell Count ( 10 9 /L) Lymphocyte Pharmacodynamics and Safety of Use in Patients Previously

More information

Supported by an unrestricted educational grant by Merck & Co.

Supported by an unrestricted educational grant by Merck & Co. Supported by an unrestricted educational grant by Merck & Co. TABLE OF CONTENTS Agenda & Faculty List...2 Course Description...3 Learning Objectives...3 Accreditation Statement & Credit Designation...3

More information

EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas

EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas Disclosure of Interests AstraZeneca (scientific advisory board) Bayer

More information

The Good, The Bad, The Needs: Current Prediction Methods Used in Program Specific Reports

The Good, The Bad, The Needs: Current Prediction Methods Used in Program Specific Reports The Good, The Bad, The Needs: Current Prediction Methods Used in Program Specific Reports Ajay K Israni, MD, MS Deputy Director, Scientific Registry of Transplant Recipients Associate Professor of Medicine,

More information

Key ASCO Presentations Issue 2, Ipilimumab Monotherapy for Patients with Melanoma and Brain Metastases

Key ASCO Presentations Issue 2, Ipilimumab Monotherapy for Patients with Melanoma and Brain Metastases Key ASCO Presentations Issue 2, 2010 Ipilimumab Monotherapy for Patients with Melanoma and Brain Metastases For more visit ResearchToPractice.com/5MJCMT2010 CME INFORMATION OVERVIEW OF ACTIVITY Each year,

More information

Poster Presented at the 2014 American College of Rheumatology Annual Meeting

Poster Presented at the 2014 American College of Rheumatology Annual Meeting Poster Presented at the 2014 American College of Rheumatology Annual Meeting Anne Winkler 1 James Mossell 2 Edmund MacLaughlin 3 Drew Johnson 4 J. Timothy Harrington 5 1 Winkler Medical Practice LLC, Springfield,

More information

Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145: 52-Week Results From the OSLER Study

Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145: 52-Week Results From the OSLER Study Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145: 52-Week Results From the OSLER Study Michael J Koren 1, Robert P Giugliano 2, Frederick Raal 3, David

More information

SUNY Binghamton, B.S. Biochemistry, 5/80 SUNY Downstate Medical Center, M.D., 6/84

SUNY Binghamton, B.S. Biochemistry, 5/80 SUNY Downstate Medical Center, M.D., 6/84 CURRICULUM VITAE RUSSELL D'AMBRA, M.D. July 2014 North Shore Diabetes & Endocrine Associates 3003 New Hyde Park Road Suite 201 New Hyde Park, New York 11042 516-327-0850 EDUCATION: POST-GRADUATE TRAINING:

More information

ROMICAT II - Rule Out Myocardial

ROMICAT II - Rule Out Myocardial ROMICAT II - Rule Out Myocardial Ischemia/Infarction Using Computer Assisted Tomography NHLBI U01HL092040 A Multicenter Randomized Comparative Effectiveness Trial of Cardiac CTA vs. Standard Evaluation

More information

Appendix K Declarations of Interests

Appendix K Declarations of Interests Appendix K Declarations of Interests Ms Theresa Shaw - Chair, Guideline Development Group Chief Executive, Foundation of Nursing Studies (FoNS), London Funding for the 'Developing Practice for Healthy

More information

JABLONSKI DEBATES PSA TESTING

JABLONSKI DEBATES PSA TESTING The JABLONSKI DEBATES PSA TESTING Getting Prostrate for the Prostate The JABLONSKI DEBATES Learning has never been this much fun (just like walking through a field littered with land mines.) The JABLONSKI

More information

KDIGO LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE

KDIGO LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE Dr. Christopher T Chan Director Division of Nephrology University Health Network Professor of Medicine University of Toronto Disclosure

More information

Slide 1. Slide 2. Slide 3. Managing Acute Heart Failure Trials and Tribulations. Declaration of

Slide 1. Slide 2. Slide 3. Managing Acute Heart Failure Trials and Tribulations. Declaration of Slide 1 Managing Acute Heart Failure Trials and Tribulations Martin R Cowie MD MSc FRCP FRCP (Ed) FESC Professor of Cardiology, Imperial College London m.cowie@imperial.ac.uk @ProfMartinCowie Slide 2 Declaration

More information

CAR T Cell Therapies Workshop

CAR T Cell Therapies Workshop CAR T Cell Therapies Workshop May 15, 2018 Hilton Chicago Continental B Chicago Table of Contents CAR T Cell Therapies Workshop Supporters... p 2 Committee Listing... p 3 Faculty Listing... p 3 Faculty

More information

SickKids Research Institute: List of Funders

SickKids Research Institute: List of Funders SickKids Research Institute: List of Funders 2009-2010 Agency Funding $ Agency Funding $ 3M Pharmaceuticals 2,901 International Council on Amino Acid Science 80,800 Abbott Diagnostics 6,639 International

More information

June 4, Via Electronic Transmission

June 4, Via Electronic Transmission June 4, 2008 Via Electronic Transmission Dr. Drew Gilpin Faust President Harvard University Massachusetts Hall Cambridge, MA 02138 Dr. Peter L. Slavin President Massachusetts General Hospital (Partners

More information

CME Information For Journal Club Course:

CME Information For Journal Club Course: Important: Once you have finished reading the document, you may choose to return to the main course room or to Jump to the Course Content Activity. To continue to the Course Content Activity: Select the

More information

American Association of Kidney Patients, Inc.

American Association of Kidney Patients, Inc. American Association of Kidney Patients, Inc. SUMMARY Mission AAKP is a national patient organization dedicated to improving the quality of life of kidney patients through education, advocacy and the fostering

More information

Global End Stage Renal Disease (ESRD) Market With Focus on Dialysis Market ( Edition) July 2017

Global End Stage Renal Disease (ESRD) Market With Focus on Dialysis Market ( Edition) July 2017 Global End Stage Renal Disease (ESRD) Market With Focus on Dialysis Market (2017-2021 Edition) July 2017 Scope of the Report Global End Stage Renal Disease Market The report titled Global End Stage Renal

More information

Erythropoiesis Stimulation and Heart Failure: Current Status

Erythropoiesis Stimulation and Heart Failure: Current Status Erythropoiesis Stimulation and Heart Failure: Current Status Marc A. Pfeffer, MD, PhD Dzau Professor of Medicine, Harvard Medical School Cardiovascular Division, Brigham & Women s Hospital Boston, Massachusetts

More information

Fellow in Nephrology at University of California, San Francisco 7/1/1982-6/30/1984

Fellow in Nephrology at University of California, San Francisco 7/1/1982-6/30/1984 Curriculum Vitae Haseeb I. Al-Mufti, MD 13939 E 14 th St, Suite 170 San Leandro, CA 94578-2613 660 4 th St, # 349 San Francisco, CA 94107-1618 Office (510) 483-2480 Fax (510) 483-4286 Email: halmufti@renalassociates.org

More information

Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis

Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis CJASN epress. Published on September 5, 2013 as doi: 10.2215/CJN.01410213 Article Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis Shobha Stack,* Glenn M. Chertow,*

More information

PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME 217 American Society of Nephrology Meeting Geoffrey A. Block 1, Pablo E. Pergola 2, Lesley

More information

Coalition for Supportive Care of Kidney Patients.

Coalition for Supportive Care of Kidney Patients. Coalition for Supportive Care of Kidney Patients www.kidneysupportivecare.org About the Coalition The Coalition for Supportive Care of Kidney Patients (CSCKP) brings together like minded people who care

More information

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3

Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3 American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a

More information

Faculty. Course Directors. Liza Blumenfeld, MA, CCC-SLP, BCS-S UC San Diego Health - Speech-Language Pathologist

Faculty. Course Directors. Liza Blumenfeld, MA, CCC-SLP, BCS-S UC San Diego Health - Speech-Language Pathologist Faculty Course Directors Liza Blumenfeld, MA, CCC-SLP, BCS-S UC San Diego Health - Speech-Language Pathologist Non-financial Disclosure: Developer of Swallow RehApp Joseph Califano, MD UC San Diego Health

More information

How the UK Renal Registry has improved the lives of renal patients

How the UK Renal Registry has improved the lives of renal patients How the UK Renal Registry has improved the lives of renal patients [is improving and will improve] Dr Fergus Caskey Medical Director of the UK Renal Registry NKF Annual Conference, Reading, 10th October

More information

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Building a clinical service for children with CKD in a developing country

Building a clinical service for children with CKD in a developing country Building a clinical service for children with CKD in a developing country ALANEPE X LATIN AMERICA CONGRESS OF PEDIATRIC NEPHROLOGY Dr. Maolynne Miller JAMAICA WEST INDIES Paediatrician Paediatric Nephrologist

More information

Oncology Pipeline Analytics

Oncology Pipeline Analytics Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to

More information

The Ohio State University Wexner Medical Center, 2018

The Ohio State University Wexner Medical Center, 2018 The Ohio State University Wexner Medical Center, 2018 The following program is a Continuing Medical Education Activity sponsored by The Ohio State University Wexner Medical Center. The design and production

More information